METHODS IN CLINICAL CANCER RESEARCH (EUROPE): A WORKSHOP

描述：(申请人描述)请求支持以举行 题为“临床癌症研究方法(欧洲)”的研讨会，将 为年轻的临床科学家提供绝佳的培训机会 临床试验的设计和临床研究的方法。组织者 认为这次研讨会既是一个合乎逻辑的延伸，也是一个有价值的 对两个年度临床方法研讨会的补充 美国(由NCI的#CA68647赠款支持)以及 在欧洲有许多药物发现和临床研究计划 已经得到了NCI超过25年的支持。(NCI的基本原理 对这些协作努力的支持在R.E.Wittes和 O·约德，《一个社区》，《肿瘤学年鉴》，1998年，9：251-254。就像 现有的计划，这次研讨会将促进两个领域的临床癌症研究 并为癌症患者带来重要的好处 在世界各地。本研讨会将： (1)向欧洲介绍好的临床试验设计原则 刚刚完成培训或已完成培训的临床研究人员 最近担任的工作人员级别的职位，即为他们提供他们需要的工具 进行试验，以得出对以下假设的最终答案 测试，并使他们能够开发新的假设，以便他们可以继续 下一阶段的研究。 (2)让年轻的临床科学家面对全方位的挑战 临床癌症研究，包括外科、放射治疗、常规和 研究抗肿瘤、基因治疗、生物治疗和临床 预防试验。 (3)培养一支训练有素、经验丰富的科研队伍，其工作将 促进更好的临床试验设计，从而加快引入 改进的癌症治疗和预防药物进入日常临床 练习和照顾病人。

DESCRIPTION: (Applicant's Description) Support is requested to hold a Workshop entitled, "Methods in Clinical Cancer Research (Europe)," that will offer an outstanding training opportunity for young clinical scientists in the design of clinical trials and methods in clinical research. The organizers consider this Workshop to be both a logical extension of and a valuable complement to both the annual Clinical Methods Workshop that takes place in the United States (supported by the NCI's grant #CA68647) as well as the numerous drug discovery and clinical research programs in Europe that have been supported by the NCI for more than 25 years. (The rationale for NCI support of these collaborative efforts is described in R. E. Wittes and O. Yoder, "One Community", Annals of Oncology, 9:251-254, 1998.) Like the existing programs, this Workshop will advance clinical cancer research in both North America and Europe and produce important benefits for cancer patients throughout the world. This Workshop will: (1) Introduce the principles of good clinical trial design to European clinical researchers who are just completing their training or who have recently assumed staff-level positions, i.e., give them the tools they need to conduct trials that will yield definitive answers to the hypotheses to be tested, and enable them to develop new hypotheses so that they can proceed to the next level of research. (2) Expose young clinical scientists to the full spectrum of challenges in clinical cancer research, including surgery, radiotherapy, conventional and investigational antineoplastics, gene therapy, biologic therapy, and clinical prevention trials. (3) Develop a cadre of well-trained, experienced researchers whose work will promote better clinical trial design and thereby hasten the introduction of improved agents for cancer therapy and prevention into everyday clinical practice and patient care.